Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PBYI | BMY | AMGN | GILD | VRTX |
| Company | Puma Biotechnology | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 2.65 | 54.00 | 320.08 | 85.05 | 454.17 |
| High | 2.71 | 54.42 | 320.20 | 85.66 | 454.36 |
| Low | 2.61 | 53.41 | 315.92 | 84.34 | 447.70 |
| Last | 2.66 | 53.44 | 317.45 | 84.43 | 448.60 |
| Change | +0.01 | -0.52 | -2.21 | -0.16 | -6.71 |
| % Change | +0.38% | -0.96% | -0.69% | -0.19% | -1.47% |
| Volume | 257,000 | 11,150,500 | 1,262,200 | 4,692,500 | 914,000 |
| 20-Day Average Volume | 302,530 | 13,196,880 | 2,074,665 | 7,669,880 | 973,300 |
| Previous Close | 2.65 | 53.96 | 319.66 | 84.59 | 455.31 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.55 | 50.74 | 326.69 | 83.43 | 468.12 |
| 20-Day Raw Stochastic | 89.13% | 83.77% | 19.59% | 82.25% | 2.12% |
| 20-Day Relative Strength | 48.69% | 64.85% | 43.60% | 66.42% | 37.86% |
| Weighted Alpha | -11.23 | +3.25 | +11.96 | +15.81 | +16.41 |
| Today's Opinion | 88% Sell | 88% Buy | 24% Buy | 88% Buy | 8% Sell |
| Previous Opinion | 88% Sell | 88% Buy | 24% Buy | 88% Buy | 8% Buy |
| Last Month's Opinion | 100% Sell | 40% Buy | 56% Buy | 88% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.31% since 09/30/24 | +3.29% since 09/30/24 | -1.48% since 09/30/24 | +0.70% since 09/30/24 | -3.54% since 09/30/24 |
| Low | 2.41 on 10/03/24 | 51.61 on 10/01/24 | 315.46 on 10/03/24 | 82.82 on 10/01/24 | 447.70 on 10/07/24 |
| High | 2.71 on 10/07/24 | 54.54 on 10/02/24 | 322.20 on 10/01/24 | 85.66 on 10/07/24 | 472.31 on 10/01/24 |
| 1-Month | |||||
| %Chg | +18.22% since 09/06/24 | +9.73% since 09/06/24 | -0.97% since 09/06/24 | +7.25% since 09/06/24 | -4.15% since 09/06/24 |
| Low | 2.25 on 09/10/24 | 47.55 on 09/09/24 | 312.16 on 09/25/24 | 78.36 on 09/09/24 | 447.70 on 10/07/24 |
| High | 2.71 on 10/07/24 | 54.54 on 10/02/24 | 339.17 on 09/23/24 | 85.66 on 10/07/24 | 490.15 on 09/16/24 |
| 3-Month | |||||
| %Chg | -9.83% since 07/05/24 | +34.75% since 07/05/24 | +2.11% since 07/05/24 | +26.60% since 07/05/24 | -5.47% since 07/05/24 |
| Low | 2.22 on 09/06/24 | 39.50 on 07/08/24 | 306.59 on 08/07/24 | 66.34 on 07/09/24 | 447.70 on 10/07/24 |
| High | 4.13 on 08/07/24 | 54.54 on 10/02/24 | 346.85 on 07/25/24 | 85.66 on 10/07/24 | 510.64 on 08/01/24 |
| 6-Month | |||||
| %Chg | -53.00% since 04/05/24 | +4.13% since 04/05/24 | +17.60% since 04/05/24 | +21.34% since 04/05/24 | +10.31% since 04/05/24 |
| Low | 2.22 on 09/06/24 | 39.35 on 07/05/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 391.01 on 04/18/24 |
| High | 6.05 on 04/09/24 | 54.54 on 10/02/24 | 346.85 on 07/25/24 | 85.66 on 10/07/24 | 510.64 on 08/01/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 127,833 | 109,382,312 | 171,476,816 | 105,386,704 | 117,494,112 |
| Shares Outstanding, K | 48,239 | 2,027,100 | 536,435 | 1,245,853 | 258,053 |
| Annual Sales | 235,640,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | 21,590,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 47,080,000 | 12,201,000,000 | 8,388,000,000 | 6,954,000,000 | 2,645,600,000 |
| Last Quarter Net Income | -4,530,000 | 1,680,000,000 | 746,000,000 | 1,614,000,000 | -3,593,600,000 |
| 60-Month Beta | 1.09 | 0.46 | 0.61 | 0.18 | 0.40 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.05 on 08/01/24 | 2.07 on 07/26/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | -12.83 on 08/01/24 |
| Latest Earnings Date | 11/07/24 | 10/31/24 | 10/30/24 | 11/07/24 | 11/04/24 |
| Most Recent Dividend | N/A | 0.600 on 10/04/24 | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A |
| Next Ex-Dividends Date | N/A | 10/04/24 | 08/16/24 | 09/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 13.26 | 39.56 | 17.07 | 17.91 | 0.00 |